Gene · 2672
Papers1,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stem Cell-Based Hair Cell Regeneration and Therapy in the Inner Ear. | Neurosci Bull | 2024 | 37787875 | PubTator, text mining | PubMed |
| Thiostrepton induces cell death of acute myeloid leukemia blasts and the associated macrophage population. | Haematologica | 2024 | 37646656 | PubTator, text mining | PubMed |
| Growth Factor Independence-1 (GFI-1) Gene Expression in Hematopoietic Stem Cell Lineage Differentiation in Low Birth Weight Newborns Compared With Normal Birth Weight Newborns at Term Pregnancy. | Cureus | 2023 | 38239528 | PubTator, text mining | PubMed |
| The Upstream 1350~1250 Nucleotide Sequences of the Human ENDOU-1 Gene Contain Critical Cis-Elements Responsible for Upregulating Its Transcription during ER Stress. | Int J Mol Sci | 2023 | 38139221 | PubTator, text mining | PubMed |
| Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets. | Cell Death Discov | 2023 | 38135679 | PubTator, text mining | PubMed |
| Haematopoietic development and HSC formation in vitro: promise and limitations of gastruloid models. | Emerg Top Life Sci | 2023 | 38095554 | PubTator, text mining | PubMed |
| Linking Prenatal Environmental Exposures to Lifetime Health with Epigenome-Wide Association Studies: State-of-the-Science Review and Future Recommendations. | Environ Health Perspect | 2023 | 38048101 | PubTator, text mining | PubMed |
| Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach. | Cell Commun Signal | 2023 | 38031192 | PubTator, text mining | PubMed |
| DNA methylation and histone post-translational modifications in atherosclerosis and a novel perspective for epigenetic therapy. | Cell Commun Signal | 2023 | 38031118 | PubTator, text mining | PubMed |
| Computational analysis of five neurodegenerative diseases reveals shared and specific genetic loci. | Comput Struct Biotechnol J | 2023 | 38022694 | PubTator, text mining | PubMed |
| Identification of a regulatory pathway governing TRAF1 via an arthritis-associated non-coding variant. | Cell Genom | 2023 | 38020975 | PubTator, text mining | PubMed |
| Enhancers dysfunction in the 3D genome of cancer cells. | Front Cell Dev Biol | 2023 | 38020908 | PubTator, text mining | PubMed |
Lipopolysaccharide (LPS) stimulation of Pancreatic Ductal Adenocarcinoma (PDAC) and macrophages activates the NLRP3 inflammasome that influences the levels of pro-inflammatory cytokines in a co-culture model. | Cancer Biol Ther | 2023 | 38018872 | PubTator, text mining | PubMed |
| A novel approach to risk exposure and epigenetics-the use of multidimensional context to gain insights into the early origins of cardiometabolic and neurocognitive health. | BMC Med | 2023 | 38012757 | PubTator, text mining | PubMed |
| Waterpipe and cigarette epigenome analysis reveals markers implicated in addiction and smoking type inference. | Environ Int | 2023 | 38006773 | PubTator, text mining | PubMed |
| Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML. | Cell Death Dis | 2023 | 37996430 | PubTator, text mining | PubMed |
| Screening for ELANE, HAX1 and GFI1 gene mutations in children with neutropenia and clinical characterization of two novel mutations in ELANE gene. | BMC Pediatr | 2023 | 37993852 | PubTator, text mining | PubMed |
| Abundant binary promoter switches in lineage-determining transcription factors indicate a digital component of cell fate determination. | Cell Rep | 2023 | 37976160 | PubTator, text mining | PubMed |
| Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy. | Acta Pharm Sin B | 2023 | 37969742 | PubTator, text mining | PubMed |
| Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas. | Cell Rep Med | 2023 | 37967556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2672/papers?page=6